Disease & disorder
sarcomatoid mesothelioma
MONDO:0006407
A diffuse malignant mesothelioma arising from the pleura and less often the peritoneum. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
sarcomatoid mesothelioma
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
3 shownPembrolizumab in Treating Patients With Malignant MesotheliomaNCT02399371 · 2015-03-31
COMPLETEDTivantinib in Treating Patients With Previously Treated Malignant MesotheliomaNCT01861301 · 2013-01-01
TERMINATEDPemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaNCT01064648 · 2010-03-15
ACTIVE_NOT_RECRUITINGDrugs being studied
Research locations
Ann ArborMichigan, United States2ChicagoIllinois, United States2DecaturIllinois, United States2DetroitMichigan, United States2IndianapolisIndiana, United States2Los AngelesCalifornia, United States2PeoriaIllinois, United States2SacramentoCalifornia, United States2SpringfieldIllinois, United States2St LouisMissouri, United States2BillingsMontana, United States1BoiseIdaho, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.